Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023
NEW YORK, Sept. 26, 2023 -- Ovid Therapeutics Inc. , a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders,...
Source: marketscreener.com